Study in Prostaglandin Associated Peri-orbitopathy Switching From Prostaglandin Monotherapy to Omidenepag Isopropyl

NCT05279716 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Normal Tension Glaucoma
Primary Open-angle Glaucoma
Glaucoma, Suspect
Ocular Hypertension

Interventions

DRUG: Eybelis ophthalmic solution 0.002%

Sponsor

Santen Pharmaceutical Asia Pte. Ltd.